2-tert-butylhydroquinone has been researched along with dicumarol in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Coyle, JT; De Long, MJ; Murphy, TH | 1 |
Nakagawa, Y | 1 |
Blei, K; Dirnagl, U; Harms, C; Harms, U; Hörtnagl, H; Kapinya, KJ; Katchanov, J | 1 |
3 other study(ies) available for 2-tert-butylhydroquinone and dicumarol
Article | Year |
---|---|
Enhanced NAD(P)H:quinone reductase activity prevents glutamate toxicity produced by oxidative stress.
Topics: Antioxidants; Cell Line; Cell Survival; Dicumarol; Excitatory Amino Acid Antagonists; Glutamates; Glutamic Acid; Glutathione; Glutathione Disulfide; Hydroquinones; Neurons; Oxidation-Reduction; Quinone Reductases; Vitamin K | 1991 |
Effects of dicoumarol on cytotoxicity caused by tert-butylhydroquinone in isolated rat hepatocytes.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Cell Survival; Dicumarol; Enzyme Inhibitors; Glutathione; Hydroquinones; In Vitro Techniques; Liver; Male; NAD(P)H Dehydrogenase (Quinone); Rats; Rats, Inbred F344 | 1996 |
Role of NAD(P)H:quinone oxidoreductase in the progression of neuronal cell death in vitro and following cerebral ischaemia in vivo.
Topics: Animals; Apoptosis; Aziridines; Brain Ischemia; Cells, Cultured; Choline; Dicumarol; Disease Models, Animal; Disease Progression; Drug Synergism; Enzyme Activation; Enzyme Inhibitors; Hydroquinones; Male; Mice; Mice, Inbred C57BL; NAD(P)H Dehydrogenase (Quinone); NADPH Dehydrogenase; Neurons; Rats; Rats, Wistar | 2003 |